Insider · CIK 0001873919
Aguilar-Cordova Estuardo
owner
Files at CADL (Candel Therapeutics, Inc.). First filing Oct 15, 2024, latest Oct 15, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $244k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 25Weak | sell | CADL Candel Therapeutics, Inc. | $244k | 40,412 | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -50,000 | $9.01 | $451k | 223,512 | Dec 30, 2024 |
| Dec 26, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $9.01 | $451k | 181,443 | Dec 30, 2024 |
| Dec 27, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -50,000 | $8.85 | $443k | 173,512 | Dec 30, 2024 |
| Dec 27, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $8.85 | $443k | 131,443 | Dec 30, 2024 |
| Dec 20, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -100,000 | $9.00 | $900k | 373,512 | Dec 26, 2024 |
| Dec 20, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -100,000 | $9.00 | $900k | 331,443 | Dec 26, 2024 |
| Dec 23, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -50,000 | $8.52 | $426k | 323,512 | Dec 26, 2024 |
| Dec 23, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $8.52 | $426k | 281,443 | Dec 26, 2024 |
| Dec 24, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | +50,000 | $8.82 | $441k | 273,512 | Dec 26, 2024 |
| Dec 24, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -50,000 | $8.82 | $441k | 231,443 | Dec 26, 2024 |
| Dec 11, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -200,000 | $8.53 | $1.7M | 673,512 | Dec 13, 2024 |
| Dec 11, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -200,000 | $8.53 | $1.7M | 631,443 | Dec 13, 2024 |
| Dec 12, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -200,000 | $10.04 | $2.0M | 473,512 | Dec 13, 2024 |
| Dec 12, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -200,000 | $10.04 | $2.0M | 431,443 | Dec 13, 2024 |
| Dec 4, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -20,000 | $4.46 | $89k | 131,335 | Dec 6, 2024 |
| Dec 5, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -20,000 | $4.79 | $96k | 111,335 | Dec 6, 2024 |
| Dec 6, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -20,000 | $5.23 | $105k | 91,335 | Dec 6, 2024 |
| Nov 25, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -20,000 | $4.97 | $99k | 151,335 | Nov 27, 2024 |
| Nov 6, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -7,500 | $5.33 | $40k | 888,512 | Nov 8, 2024 |
| Nov 6, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -7,500 | $5.33 | $40k | 846,443 | Nov 8, 2024 |
| Nov 7, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -7,500 | $5.19 | $39k | 881,012 | Nov 8, 2024 |
| Nov 7, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -7,500 | $5.19 | $39k | 838,943 | Nov 8, 2024 |
| Nov 8, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -7,500 | $4.92 | $37k | 873,512 | Nov 8, 2024 |
| Nov 8, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -7,500 | $4.92 | $37k | 831,443 | Nov 8, 2024 |
| Oct 30, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -6,000 | $5.38 | $32k | 911,012 | Nov 1, 2024 |
| Oct 30, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -6,000 | $5.38 | $32k | 868,943 | Nov 1, 2024 |
| Oct 31, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -7,500 | $5.30 | $40k | 903,512 | Nov 1, 2024 |
| Oct 31, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -7,500 | $5.30 | $40k | 861,443 | Nov 1, 2024 |
| Nov 1, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -7,500 | $5.27 | $40k | 896,012 | Nov 1, 2024 |
| Nov 1, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADLindirect: By LKA 2022 Revocable Trust | -7,500 | $5.27 | $40k | 853,943 | Nov 1, 2024 |
| Oct 24, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -16,427 | $5.53 | $91k | 903,034 | Oct 28, 2024 |
| Oct 24, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -1,194 | $5.72 | $6,830 | 901,840 | Oct 28, 2024 |
| Oct 25, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -1,597 | $5.80 | $9,263 | 900,243 | Oct 28, 2024 |
| Oct 28, 2024 | CADL Candel Therapeutics, Inc. | DDisposition to issuer CADL | -11,711 | $5.58 | $65k | 888,532 | Oct 28, 2024 |
| Oct 11, 2024 | CADL Candel Therapeutics, Inc. | SOpen-market sale CADL | -15,000 | $6.05 | $91k | 944,873 | Oct 15, 2024 |
| Oct 14, 2024 | CADL Candel Therapeutics, Inc. | SOpen-market sale CADL | -15,000 | $6.02 | $90k | 929,873 | Oct 15, 2024 |
| Oct 15, 2024 | CADL Candel Therapeutics, Inc. | SOpen-market sale CADL | -10,412 | $6.03 | $63k | 919,461 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.